Subscribe to our Newsletters !!
On September 16, 2024, HiMedia Laboratories proudl
Particles in suspensions are abundant in biologica
Dräger India is proud to announce the launch of t
Husky Technologies™ is excited to announce a maj
Alembic Pharmaceuticals Limited (Alembic) today an
It is important to understand that natural remedie
Dear Readers, Welcome to the latest issue of Micr
During Friday trade the pharma stocks were the top gainer among the sectoral indices on NSE. The Nifty Pharma index was trading 3.02 per cent up at 8,502 around 12:25 pm. The pharma stocks were rallying amid a fresh fall in the Indian rupee against the US dollar.
The Sun Pharmaceuticals were the top gainer leading the pack (up 6.03 per cent), followed by Dr.Reddy’s Laboratories ( up 3.56 per cent) and Lupin ( up 3.38 per cent). Whereas Aurobindo Pharma (up 2.78 per cent), CadilaHealthcareNSE (up 2.64 per cent), Glenmark Pharmaceuticals (up 2.52 per cent), CiplaNSE (up 2.27 per cent) and Biocon (up 0.58 per cent) were also in the gainer’s list.
rnrn
As per the PTI reporter the Aurobindo Pharma said that they have received the final approval from the US health regulator to manufacture Omeprazole delayed-release tablets. These drugs are used for the treatment of frequent heartburn..
However, Divi’s laboratories and Piramal enterprises were the two stocks which were in the red.
As per the PTI reporter the Aurobindo Pharma said that they have received the final approval from the US health regulator to manufacture Omeprazole delayed-release tablets. These drugs are used for the treatment of frequent heartburn.
Among the 50 stocks in the nifty index, 16 were trading in the green where as 34 were in the red line.
